Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rel/NF-κB Transcription Factors Emerged at the Onset of Opisthokonts. | Genome Biol Evol | 2022 | 34999783 | PubTator, text mining | PubMed |
| Improvement of the affinity of an anti-rat P2X4 receptor antibody by introducing electrostatic interactions. | Sci Rep | 2022 | 34996944 | PubTator, text mining | PubMed |
| RBC membrane biomechanics and Plasmodium falciparum invasion: probing beyond ligand-receptor interactions. | Trends Parasitol | 2022 | 34991983 | PubTator, text mining | PubMed |
Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB). | Pediatr Crit Care Med | 2022 | 34989711 | PubTator, text mining | PubMed |
What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding. | Pediatr Crit Care Med | 2022 | 34989701 | PubTator, text mining | PubMed |
| Accurate long-read sequencing allows assembly of the duplicated RHD and RHCE genes harboring variants relevant to blood transfusion. | Am J Hum Genet | 2022 | 34968422 | PubTator, text mining | PubMed |
| ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. | Virulence | 2022 | 34967260 | PubTator, text mining | PubMed |
| Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells. | Neoplasia | 2022 | 34959030 | PubTator, text mining | PubMed |
| The contribution and potential of older blood donors in Asia Pacific regions. | Transfus Med | 2022 | 34954862 | PubTator, text mining | PubMed |
| Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV-2 convalescent plasma donors. | Transfusion | 2022 | 34936102 | PubTator, text mining | PubMed |
| An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype. | Transfusion | 2022 | 34936100 | PubTator, text mining | PubMed |
| Occult alloimmunization to the D antigen (RhD) related to graft versus host disease and its treatment. | Transfus Clin Biol | 2022 | 34923150 | PubTator, text mining | PubMed |
| A novel RHD (c.509T>G, p.Met170Arg) allele shows weakened D expression. | Transfusion | 2022 | 34921421 | PubTator, text mining | PubMed |
| Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells. | Transl Oncol | 2022 | 34906889 | PubTator, text mining | PubMed |
| A novel RHD allele, RHD*1166delA, with D-negative phenotype identified in a Chinese family. | Transfusion | 2022 | 34888890 | PubTator, text mining | PubMed |
| Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients. | Hematol Transfus Cell Ther | 2022 | 34870100 | PubTator, text mining | PubMed |
| Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection. | J Clin Virol | 2022 | 34861600 | PubTator, text mining | PubMed |
| FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas. | Mol Oncol | 2022 | 34850536 | PubTator, text mining | PubMed |
| Rhesus isoimmunisation in unsensitised RhD-negative individuals seeking abortion at less than 12 weeks' gestation: a systematic review. | BMJ Sex Reprod Health | 2022 | 34819315 | PubTator, text mining | PubMed |
| PostCOVID effect on endothelial function in hypertensive patients: A new research opportunity. | J Clin Hypertens (Greenwich) | 2022 | 34786820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=50